The Effect of Aftins on the Mitochondria
Overview
Alzheimer’s disease is a debilitating disease that causes memory loss in individuals. Aß accumulates in the brain of individuals with Alzheimer’s, however, the reason for Aß being produced and the cause of Alzheimer’s is unknown. There are numerous hypotheses for why Alzheimer’s disease occurs. Two of these hypotheses are the amyloid cascade hypothesis and the mitochondrial cascade hypothesis. The amyloid cascade hypothesis states that the accumulation of Aß causes Alzheimer’s while the mitochondrial cascade hypothesis states that mitochondrial dysfunction causes Alzheimer’s disease. There are drugs that cause an increase in the production of Aß, aftins are one of these. These drugs are not always looked at from the perspective of the mitochondria and how the mitochondria affect the production of Aß. If aftins affect the mitochondria and cause an increase in Aß production, then further evidence for the mitochondria playing a role in the production of Aß will be acquired because a relationship between the mitochondria and Aß production will be shown. In an effort to look at aftins from the perspective of the mitochondria, SY5Y and iPSC-derived neurons were treated with aftins and the mitochondria were assessed in different ways. It was found that the mitochondria were affected and a relationship between the change in the mitochondria and the production of Aß was observed. This leads to the conclusion that the mitochondria do play a significant role in the production of Aß and could potentially be the cause of Alzheimer’s disease.
Competition history
- JSHS 2022
Resources
Related projects
ISEF · 2023
Alzheimer's and Aftins: Understanding the Role of Mitochondria in Alzheimer's Disease
CSEF · 2018
Mitochondrial Dysfunction: A Biochemical Pathway for Early Detection of Alzheimer's Disease
ISEF · 2024
MFN2, A Potential Therapeutic Target for Alzheimer's Disease
AJAS · 2026
Influence of Glucose Deprivation on Amyloid Beta Neurotoxicity
ISEF · 2024
A Mechanistic Analysis of Intraneuronal Amyloid Beta Aggregation Caused by Cellular Dysfunction in Alzheimer’s Disease
CSEF · 2010
Alzheimer's and Inflammation: Exploring Enzymatic Pathways Involved in Beta Amyloid Induced TNF alpha Production
ISEF · 2023
MFN2: A Novel Therapeutic Target for Alzheimer's Disease
CSEF · 2026
Linking ER–Mitochondria Calcium Flux to Oxidative Stress and Protein Clearance Deficits in Alzheimer’s Disease
Closest projects by meaning, across every fair and year in the corpus.